Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von SERVIER
EUROPA-Studie (Perindopril) (60 Abbildungen)
Übersicht
Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken)


Zum ersten Bild Abb. 25: EUROPA-Studie - Endpunkte Abb. 26: EUROPA-Studie - Studiendesign Abb. 27: EUROPA-Studie - Patientenauswahl Aktuelles Bild - Abb. 28: EUROPA-Studie - KHK Abb. 29: EUROPA-Studie - Charakteristik Abb. 30: EUROPA-Studie - Patientenrekrutierung Abb. 31: EUROPA-Studie - Zentren Zum letzten Bild
Abbildung 28: EUROPA-Studie - KHK
EUROPA includes 100 % of patients with proven 100 % coronary artery disease. 12,218 patients aged 26 to 89 years (mean age 60 years) without heart failure were recruited and randomised if they had documented CAD, which was defined as either: - A history of previous MI at least three months before selection - A history of PTCA or CABG at least 6 months old - Significant coronary stenosis on coronary angiogram - In males with a history of chest pain, by a positive exercise test, stress echo or scintiography
 
EUROPA-Studie - KHK
Vorheriges Bild Nächstes Bild   


Abbildung 28: EUROPA-Studie - KHK
EUROPA includes 100 % of patients with proven 100 % coronary artery disease. 12,218 patients aged 26 to 89 years (mean age 60 years) without heart failure were recruited and randomised if they had documented CAD, which was defined as either: - A history of previous MI at least three months before selection - A history of PTCA or CABG at least 6 months old - Significant coronary stenosis on coronary angiogram - In males with a history of chest pain, by a positive exercise test, stress echo or scintiography
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung